We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+1.12%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.54B
AUM Growth
-$175M
(-2.3%)
Cap. Flow
-$162M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.97%
Holding
2,467
New
22
Increased
509
Reduced
1,757
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$26.2M |
| 2 |
Microsoft
MSFT
|
+$22.3M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$17.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$11.3M |
| 5 |
Intel
INTC
|
+$11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$8.87M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$7.51M |
| 3 |
Wells Fargo
WFC
|
+$6.77M |
| 4 |
JPMorgan Chase
JPM
|
+$6.34M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
+$5.81M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.12% |
| 2 | Financials | 16.41% |
| 3 | Healthcare | 13.76% |
| 4 | Industrials | 8.56% |
| 5 | Consumer Discretionary | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEAT
2226
DELISTED
BioTelemetry, Inc.
BEAT
| $70K | ﹤0.01% |
10,439
-2,359
| -18% | -$16.5K |
|
2227
Commercial Vehicle Group
CVGI
$158M
| $65K | ﹤0.01% |
10,507
-2,386
| -19% | -$21K |
|
2228
Destination XL Group
DXLG
$34.5M
| $65K | ﹤0.01% |
13,762
-3,113
| -18% | -$16.1K |
|
2229
Lineage Cell Therapeutics
LCTX
$267M
| $65K | ﹤0.01% |
25,619
-5,801
| -18% | -$14K |
|
2230
QuickLogic
QUIK
$237M
| $65K | ﹤0.01% |
1,564
-354
| -18% | -$18.5K |
|
|
FXEN
2231
DELISTED
FX ENERGY INC
FXEN
| $65K | ﹤0.01% |
21,415
-4,858
| -18% | -$15.6K |
|
|
ALR
2232
DELISTED
AlerisLife Inc
ALR
| $64K | ﹤0.01% |
1,689
-382
| -18% | -$17.3K |
|
|
PRGX
2233
DELISTED
PRGX Global, Inc.
PRGX
| $64K | ﹤0.01% |
10,854
-3,623
| -25% | -$22.7K |
|
|
SHYF
2234
DELISTED
The Shyft Group
SHYF
| $63K | ﹤0.01% |
13,530
-4,440
| -25% | -$21.7K |
|
2235
Curis
CRIS
$9.1M
| $62K | ﹤0.01% |
22
-4
| -15% | -$13.5K |
|
|
CETV
2236
DELISTED
Central European Media Enterprises Ltd
CETV
| $62K | ﹤0.01% |
27,707
-6,262
| -18% | -$15.5K |
|
|
CACB
2237
DELISTED
Cascade Bancorp
CACB
| $62K | ﹤0.01% |
12,187
-2,753
| -18% | -$14.4K |
|
|
MRGE
2238
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
| $62K | ﹤0.01% |
28,094
-6,362
| -18% | -$15.5K |
|
|
HNR
2239
DELISTED
Harvest Natural Resources
HNR
| $61K | ﹤0.01% |
4,134
-932
| -18% | -$17K |
|
|
WLT
2240
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
| $61K | ﹤0.01% |
25,928
-5,860
| -18% | -$30.3K |
|
2241
Casella Waste Systems
CWST
$5.73B
| $60K | ﹤0.01% |
15,487
-3,510
| -18% | -$16.3K |
|
2242
QuinStreet
QNST
$861M
| $60K | ﹤0.01% |
14,500
-3,356
| -19% | -$16.5K |
|
|
FLNA
2243
Filana Therapeutics
FLNA
$45M
| $59K | ﹤0.01% |
2,160
-488
| -18% | -$14.8K |
|
|
BPTH
2244
DELISTED
Bio-Path Holdings Inc
BPTH
| $59K | ﹤0.01% |
7
-2
| -22% | -$19.3K |
|
|
ACW
2245
DELISTED
Accuride Corp
ACW
| $58K | ﹤0.01% |
15,276
-3,459
| -18% | -$16.5K |
|
|
FST
2246
DELISTED
FOREST OIL CORPORATION
FST
| $58K | ﹤0.01% |
49,862
-12,272
| -20% | -$22.3K |
|
2247
Corcept Therapeutics
CORT
$10.4B
| $57K | ﹤0.01% |
21,201
-4,799
| -18% | -$12.7K |
|
|
AMPE
2248
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $57K | ﹤0.01% |
54
-12
| -18% | -$20.2K |
|
|
ALIM
2249
DELISTED
Alimera Sciences
ALIM
| $56K | ﹤0.01% |
695
-157
| -18% | -$13.4K |
|
|
CYTR
2250
DELISTED
CytRx Corp
CYTR
| $56K | ﹤0.01% |
3,663
-828
| -18% | -$16.4K |
|
Similar funds
ProShare Advisors's Q3 2014 Portfolio in Review
As of Q3 2014, ProShare Advisors held 2,467 positions worth $7.54B, down 2.3% from $7.72B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
ProShare Advisors's Q3 2014 filing shows 22 new, 509 increased, 1,757 reduced and 175 closed positions. Its largest new stake was Discovery, Inc. Series C Common Stock: 80,042 shares worth $2.98M. The largest sale was ExxonMobil, an estimated $8.87M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- ProShare Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 80,042 shares worth $2.98M.
- ProShare Advisors added most to Apple in Q3 2014, an estimated $26.2M increase.
- ProShare Advisors's biggest Q3 2014 reduction was ExxonMobil, cutting an estimated $8.87M.
- ProShare Advisors fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $5.81M.
- ProShare Advisors's ten largest holdings make up 16% of its $7.54B portfolio in Q3 2014.
- ProShare Advisors opened 22 new positions and closed 175 in Q3 2014.
- ProShare Advisors's portfolio value fell 2.3% quarter-over-quarter to $7.54B.
Based on ProShare Advisors's 13F filing for Q3 2014, filed 6 Nov 2014.